Janus Henderson Group PLC Crinetics Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,429,450 shares of CRNX stock, worth $136 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,429,450
Previous 2,455,661 1.07%
Holding current value
$136 Million
Previous $110 Million 12.83%
% of portfolio
0.07%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$43.83 - $54.98 $1.15 Million - $1.44 Million
-26,211 Reduced 1.07%
2,429,450 $124 Million
Q2 2024

Aug 14, 2024
BUY
$42.12 - $51.91 $20.1 Million - $24.8 Million
477,489 Added 24.14%
2,455,661 $110 Million
Q1 2024

May 15, 2024
BUY
$34.76 - $46.81 $49.9 Million - $67.2 Million
1,434,909 Added 264.13%
1,978,172 $92.6 Million
Q4 2023

Feb 14, 2024
SELL
$25.62 - $37.07 $1.16 Million - $1.67 Million
-45,115 Reduced 7.67%
543,263 $19.3 Million
Q3 2023

Nov 14, 2023
BUY
$15.97 - $30.59 $1.88 Million - $3.6 Million
117,642 Added 24.99%
588,378 $17.5 Million
Q2 2023

Aug 14, 2023
BUY
$15.73 - $23.6 $857,033 - $1.29 Million
54,484 Added 13.09%
470,736 $8.48 Million
Q1 2023

May 15, 2023
BUY
$15.31 - $21.1 $152,916 - $210,746
9,988 Added 2.46%
416,252 $6.69 Million
Q4 2022

Feb 14, 2023
BUY
$15.49 - $19.05 $3.35 Million - $4.12 Million
216,416 Added 113.99%
406,264 $7.43 Million
Q3 2022

Nov 14, 2022
BUY
$18.11 - $22.37 $3.44 Million - $4.25 Million
189,848 New
189,848 $3.73 Million
Q2 2020

Aug 14, 2020
SELL
$13.04 - $23.23 $6.41 Million - $11.4 Million
-491,691 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$11.52 - $26.46 $32,474 - $74,590
2,819 Added 0.58%
491,691 $7.23 Million
Q4 2019

Feb 18, 2020
SELL
$15.24 - $25.09 $118,689 - $195,400
-7,788 Reduced 1.57%
488,872 $12.3 Million
Q3 2019

Nov 14, 2019
SELL
$14.91 - $25.01 $42,970 - $72,078
-2,882 Reduced 0.58%
496,660 $7.47 Million
Q2 2019

Jul 31, 2019
BUY
$21.48 - $27.71 $240,039 - $309,659
11,175 Added 2.29%
499,542 $12.5 Million
Q1 2019

Apr 30, 2019
SELL
$21.07 - $29.31 $873,541 - $1.22 Million
-41,459 Reduced 7.83%
488,367 $11.1 Million
Q4 2018

Feb 06, 2019
BUY
$22.4 - $35.39 $113,836 - $179,851
5,082 Added 0.97%
529,826 $15.9 Million
Q3 2018

Nov 09, 2018
BUY
$22.66 - $36.8 $11.9 Million - $19.3 Million
524,744 New
524,744 $15 Million

Others Institutions Holding CRNX

# of Institutions
241
Shares Held
79.6M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $3.01B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email